Administration, Intranasal
"Administration, Intranasal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Delivery of medications through the nasal mucosa.
| Descriptor ID |
D000281
|
| MeSH Number(s) |
E02.319.267.120.655.500
|
| Concept/Terms |
Administration, Intranasal- Administration, Intranasal
- Intranasal Drug Administration
- Drug Administration, Intranasal
- Intranasal Administration
- Administrations, Intranasal
- Intranasal Administrations
- Administration, Intranasal Drug
- Administrations, Intranasal Drug
- Drug Administrations, Intranasal
- Intranasal Drug Administrations
- Administration, Nasal
- Administrations, Nasal
- Nasal Administration
- Nasal Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Intranasal".
Below are MeSH descriptors whose meaning is more specific than "Administration, Intranasal".
This graph shows the total number of publications written about "Administration, Intranasal" by people in this website by year, and whether "Administration, Intranasal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 4 | 4 |
| 1998 | 0 | 6 | 6 |
| 1999 | 0 | 3 | 3 |
| 2000 | 0 | 5 | 5 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 4 | 4 |
| 2003 | 0 | 3 | 3 |
| 2004 | 0 | 6 | 6 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 5 | 5 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 3 | 3 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 4 | 4 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 4 | 5 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 2 | 2 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 3 | 3 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Intranasal" by people in Profiles.
-
Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization. Front Immunol. 2024; 15:1480976.
-
Intranasal sensitization model of alopecia areata using pertussis toxin as adjuvant. Front Immunol. 2024; 15:1469424.
-
Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters. Nat Commun. 2024 Jul 23; 15(1):6193.
-
An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models. Nat Commun. 2024 Jul 18; 15(1):6053.
-
Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques. Nature. 2024 Feb; 626(7998):385-391.
-
Intranasal ketamine for pediatric emergency department lacerations. Am J Emerg Med. 2023 06; 68:206.
-
Reconsidering "dissociation" as a predictor of antidepressant efficacy for esketamine. Psychopharmacology (Berl). 2023 Apr; 240(4):827-836.
-
Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamsters. Nat Commun. 2022 11 10; 13(1):6792.
-
Mucosal Vaccination With Recombinant Tm-WAP49 Protein Induces Protective Humoral and Cellular Immunity Against Experimental Trichuriasis in AKR Mice. Front Immunol. 2022; 13:800295.
-
Intranasal oxytocin administration improves mood in new mothers with moderate low mood but not in mothers with elevated symptoms of postnatal depression: A randomised controlled trial. J Affect Disord. 2022 03 01; 300:358-365.